{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Intractable Eye Pain in a Patient With Sclerosing Orbital Pseudotumor

Activity Steps


NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the pathophysiology and pain symptoms of idiopathic sclerosing orbital pseudotumors.
  2. Identify the most common interventions used to treat patients with idiopathic sclerosing orbital pseudotumors by members of the multidisciplinary team.
  3. List items in a therapeutic armamentarium to prevent hospital readmission for pseudotumor-related pain.

Learning Outcomes

By the conclusion of this activity, a majority of the participants of this activity will demonstrate knowledge of an interdisciplinary multimodal approach to managing sclerosing orbital pseudotumor by achieving a passing score on the posttest.
Price: $49.00


  • ANCC 2.0 CH / 0.5 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: TPM0624
Published: Jun 2024
Expires: 6/5/2026
Required Passing Score: 8/10 (80%)
Authors: Carol Apai, MD; Akwasi Amponsah, MD